You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 23 results:

Author Title Type [ Year

]

Filters: Keyword is Glomerular Filtration Rate and Author is Kestenbaum, Bryan [Clear All Filters]

2007

Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JKirk, Fried LF. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007 ;50(2):239-47.

2009

Asselbergs FW, Mozaffarian D, Katz R, Kestenbaum B, Fried LF, Gottdiener JS, Shlipak MG, Siscovick DS. Association of renal function with cardiac calcifications in older adults: the cardiovascular health study. Nephrol Dial Transplant. 2009 ;24(3):834-40.

Shlipak MG, Katz R, Kestenbaum B, Fried LF, Siscovick D, Sarnak MJ. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis. 2009 ;204(1):298-303.

de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, Rifkin DE, Sarnak MJ, Shlipak MG, Siscovick DS. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009 ;32(10):1833-8.

de Boer IH, Katz R, Fried LF, Ix JH, Luchsinger J, Sarnak MJ, Shlipak MG, Siscovick DS, Kestenbaum B. Obesity and change in estimated GFR among older adults. Am J Kidney Dis. 2009 ;54(6):1043-51.

Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, Shlipak M, Siscovick D, Kestenbaum B. Physical activity and rapid decline in kidney function among older adults. Arch Intern Med. 2009 ;169(22):2116-23.

Shlipak MG, Katz R, Kestenbaum B, Siscovick D, Fried L, Newman A, Rifkin D, Sarnak MJ. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009 ;20(12):2625-30.

Shlipak MG, Katz R, Kestenbaum B, Fried LF, Newman AB, Siscovick DS, Stevens L, Sarnak MJ. Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol. 2009 ;30(3):171-8.

2010

Menon V, Katz R, Mukamal K, Kestenbaum B, de Boer IH, Siscovick DS, Sarnak MJ, Shlipak MG. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010 ;25(10):3301-7.

Rifkin DE, Katz R, Fried LF, Kestenbaum B, Jenny NSwords, Newman AB, Siscovick DS, Shlipak MG, Sarnak MJ. Association between baseline kidney function and change in CRP: an analysis of the cardiovascular health study. Nephron Clin Pract. 2010 ;115(2):c114-21.

Deo R, Sotoodehnia N, Katz R, Sarnak MJ, Fried LF, Chonchol M, Kestenbaum B, Psaty BM, Siscovick DS, Shlipak MG. Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes. 2010 ;3(2):159-64.

Deo R, Katz R, Kestenbaum B, Fried L, Sarnak MJ, Psaty BM, Siscovick DS, Shlipak MG. Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail. 2010 ;16(1):55-60.

Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, Shlipak MG. Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant. 2010 ;25(1):119-24.

2011

Peralta CA, Katz R, Shlipak M, Dubin R, DeBoer I, Jenny N, Fitzpatrick A, Koro C, Kestenbaum B, Ix J, et al. Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2). Am J Nephrol. 2011 ;34(6):512-8.

de Boer IH, Katz R, Chonchol M, Ix JH, Sarnak MJ, Shlipak MG, Siscovick DS, Kestenbaum B. Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol. 2011 ;6(9):2141-9.

2012

Pham H, Robinson-Cohen C, Biggs ML, Ix JH, Mukamal KJ, Fried LF, Kestenbaum B, Siscovick DS, de Boer IH. Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephrol. 2012 ;7(4):588-94.

de Boer IH, Katz R, Chonchol MB, Fried LF, Ix JH, Kestenbaum B, Mukamal KJ, Peralta CA, Siscovick DS. Insulin resistance, cystatin C, and mortality among older adults. Diabetes Care. 2012 ;35(6):1355-60.

Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG. The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis. 2012 ;59(3):356-63.

2014

de Boer IH, Sachs MC, Chonchol M, Himmelfarb J, Hoofnagle AN, Ix JH, Kremsdorf RA, Lin YS, Mehrotra R, Robinson-Cohen C, et al. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. Am J Kidney Dis. 2014 ;64(2):187-97.

Mathew JS, Sachs MC, Katz R, Patton KK, Heckbert SR, Hoofnagle AN, Alonso A, Chonchol M, Deo R, Ix JH, et al. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation. 2014 ;130(4):298-307.

2015

Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Clin J Am Soc Nephrol. 2015 ;10(2):205-14.

2016

Bansal N, Katz R, Seliger S, DeFilippi C, Sarnak MJ, Delaney JA, Christenson R, de Boer IH, Kestenbaum B, Robinson-Cohen C, et al. Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS). Am J Kidney Dis. 2016 ;67(6):994-6.

2017

Zaheer S, de Boer IH, Allison M, Brown JM, Psaty BM, Robinson-Cohen C, Michos ED, Ix JH, Kestenbaum B, Siscovick D, et al. Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function. J Clin Endocrinol Metab. 2017 ;102(4):1387-1395.